Accustem Sciences Inc. (ACUT)

OTCMKTS: ACUT · Delayed Price · USD

0.410

+0.010 (2.50%)

Jul 2, 2024, 3:23 PM EDT - Market closed

Accustem Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021
Selling, General & Admin	3.48	0.6
Research & Development	0.27	0.07
Operating Expenses	3.75	0.67
Operating Income	-3.75	-0.67
Pretax Income	-3.75	-0.67
Net Income	-3.75	-0.67
Shares Outstanding (Basic)	11	10
Shares Outstanding (Diluted)	11	10
Shares Change	10.17%	-
EPS (Basic)	-0.34	-0.07
EPS (Diluted)	-0.34	-0.07
Free Cash Flow	-1.81	0
Free Cash Flow Per Share	-0.16	-
EBITDA	-3.75	-0.67
Depreciation & Amortization	0	0
EBIT	-3.75	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.